Summit Financial Group, Inc. Abbott Laboratories Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Summit Financial Group, Inc. holds 5,623 shares of ABT stock, worth $663,289. This represents 0.23% of its overall portfolio holdings.

Number of Shares

5,623

Previous 5,623 -0.0%

Holding current value

$663,289

Previous $618,000 3.4%

% of portfolio

0.23%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$90.19 - $110.4 $23,178 - $28,372	257 Added 4.79%	5,623 $618,000
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $61,139 - $73,356	-640 Reduced 10.66%	5,366 $519,000
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $7,558 - $8,421	-75 Reduced 1.23%	6,006 $654,000
Q1 2023 Apr 11, 2023	SELL	$96.86 - $114.01 $12,591 - $14,821	-130 Reduced 2.09%	6,081 $615,000
Q4 2022 Jan 09, 2023	SELL	$95.06 - $111.52 $17,300 - $20,296	-182 Reduced 2.85%	6,211 $682,000
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $29,318 - $33,945	303 Added 4.98%	6,393 $618,000
Q1 2022 Apr 08, 2022	SELL	$114.02 - $139.04 $3,420 - $4,171	-30 Reduced 0.49%	6,090 $721,000
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $25,185 - $30,838	-218 Reduced 3.44%	6,120 $862,000
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $86,328 - $95,504	-740 Reduced 10.45%	6,338 $749,000
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $33,852 - $39,849	320 Added 4.74%	7,078 $821,000
Q1 2021 Apr 07, 2021	SELL	$108.84 - $128.23 $111,561 - $131,435	-1,025 Reduced 13.17%	6,758 $810,000
Q4 2020 Jan 07, 2021	SELL	$105.0 - $114.42 $23,625 - $25,744	-225 Reduced 2.81%	7,783 $852,000
Q3 2020 Oct 05, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 1.23%	8,008 $871,000
Q1 2020 Apr 03, 2020	BUY	$62.82 - $91.86 $13,820 - $20,209	220 Added 2.79%	8,108 $640,000
Q3 2019 Oct 09, 2019	BUY	$81.84 - $88.74 $23,569 - $25,557	288 Added 3.79%	7,888 $660,000
Q2 2019 Jul 03, 2019	SELL	$72.88 - $85.0 $3,279 - $3,825	-45 Reduced 0.59%	7,600 $639,000
Q1 2019 Apr 03, 2019	SELL	$66.22 - $80.06 $3,642 - $4,403	-55 Reduced 0.71%	7,645 $611,000
Q3 2018 Oct 03, 2018	SELL	$60.81 - $73.36 $5,959 - $7,189	-98 Reduced 1.26%	7,700 $565,000
Q2 2018 Jul 03, 2018	BUY	$57.57 - $63.54 $17,271 - $19,062	300 Added 4.0%	7,798 $475,000
Q1 2018 Apr 04, 2018	SELL	$56.27 - $63.62 $11,254 - $12,724	-200 Reduced 2.6%	7,498 $449,000
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $369,965 - $412,920	7,698	7,698 $411,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Abbott Laboratories Transaction History